Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Vaishali Pharma Ltd

VAISHALI.NS ✓ COMPLIANTFree checks used up today ☆ Track — members

NSE · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$0.08

▲ +0.28%

Market Cap $10.15M · Vol 31.28K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

9.76

FWD: N/A

Market Cap

$10.15M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

55.91

Momentum

Beta

0.92

vs Market

52W High

$0.10

32.77% below

52W Low

$0.05

48.91% above

Volume

31.28K

Avg 107.58K

P/B

0.92

Price-to-book

ROE

N/A

Return on equity

Free Float

N/A

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Vaishali Pharma Ltd (VAISHALI.NS) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does VAISHALI.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+4.59%

-11.40%

-16.53%

+2.17%

YTD

-17.98%

-26.05%

-54.82%

+100.28%

Financials & Valuation

TTM · Annual

Total Revenue	$11.64M
Net Income	$431.39K
Revenue Growth (YoY)	-3.60%
Gross Margin	12.00%
Operating Margin	3.23%
Net Profit Margin	3.71%
ROE	N/A
ROA · ROIC	4.62% · 6.66%

P/E Ratio	9.76
Forward P/E (FY1)	N/A
PEG Ratio	0.04
P/S	0.59
P/B	0.92
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	135.00M

Technical Indicators

50-Day SMA	$0.08
200-Day SMA	$0.08
RSI (14)	55.91
Beta	0.92
52-Week High	$0.10
52-Week Low	$0.05

Volume Today	31.28K
Avg Daily Volume (30D)	107.58K
Relative Volume	0.29x
Volatility (10D)	23.62
Volatility (30D)	35.40
Free Float	N/A

Analyst Consensus

N/A

Current Price $0.08

Mean Target N/A

52W Low$0.05 52W High$0.10

Current

Target

$0.05 $0.10

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE

FIGIBBG00HJ4N0X1

ISININE972X01022

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Company -0.70% JNJ Johnson & Johnson +1.11% ABBV AbbVie Inc. -0.18% NVS Novartis AG -0.04% NOVN.S Novartis AG +1.11%

Company Profile

Vaishali Pharma Limited is an India-based pharmaceutical company. The Company is in the pharmaceutical business, mainly dealing in active pharmaceutical ingredients, pharmaceutical formulations, surgical products, and veterinary supplements, operating in domestic and export markets. Its product categories include active pharmaceutical ingredients (APIs), formulation brands, formulations, herbal, nutraceutical, oncology, surgical, and veterinary. The Company has manufactured and exported approximately 250 formulations and specializes in manufacturing tailor-made formulations. It offers APIs, including antibiotics, anti-ulcer, anti-inflammatory/analgesic/ anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, antiviral, antifungal, skeletal muscle relaxant, and anthelmintic drugs, excipients, topical steroids, corticosteroids, and enzymes. It has a global presence in Asia & Pacific, Africa, the Commonwealth of Independent States, America, and the Middle East.